Fierce Biotech is a news and analysis brand focused on the biopharma industry. We provide timely reporting, data and context on drug development and the companies behind new therapies, helping industry professionals, investors and policy watchers understand what matters and why.

Our coverage spans the full lifecycle of medicines — from early research and clinical data through regulatory approvals, payer negotiations, manufacturing, marketing, intellectual property disputes, government investigations, and M&A activity. Beyond daily reporting, the Fierce Biotech team produces special reports and data-driven pieces that highlight industry trends and financial developments.

Fierce Biotech is part of Questex and connects readers to newsletters, events and resources for the life sciences community.